{"GPL18189": [{"GSM1313019": [{"title": "T47D untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 1"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313020": [{"title": "T47D untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 1"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313021": [{"title": "T47D untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 1"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313022": [{"title": "T47D untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313023": [{"title": "T47D untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313024": [{"title": "T47D untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313025": [{"title": "T47D treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313026": [{"title": "T47D treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313027": [{"title": "T47D treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313028": [{"title": "T47D treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313029": [{"title": "T47D treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313030": [{"title": "T47D treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313031": [{"title": "T47D treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313032": [{"title": "T47D treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313033": [{"title": "T47D treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313034": [{"title": "T47D treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313035": [{"title": "T47D treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313036": [{"title": "T47D treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313037": [{"title": "T47D treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313038": [{"title": "T47D treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313039": [{"title": "T47D treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313040": [{"title": "T47D treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313041": [{"title": "T47D treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313042": [{"title": "T47D treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "T47D_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313043": [{"title": "T47D untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 5"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313044": [{"title": "T47D untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 5"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313045": [{"title": "T47D treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313046": [{"title": "T47D treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313047": [{"title": "T47D untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 6"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313048": [{"title": "T47D untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D untreated_day 6"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313049": [{"title": "T47D treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313050": [{"title": "T47D treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "T47D_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: T47D;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313051": [{"title": "MDA-MB-134VI untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313052": [{"title": "MDA-MB-134VI untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313053": [{"title": "MDA-MB-134VI untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313054": [{"title": "MDA-MB-134VI untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313055": [{"title": "MDA-MB-134VI untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313056": [{"title": "MDA-MB-134VI untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313057": [{"title": "MDA-MB-134VI treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313058": [{"title": "MDA-MB-134VI treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313059": [{"title": "MDA-MB-134VI treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313060": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313061": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313062": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313063": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313064": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313065": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313066": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313067": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313068": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313069": [{"title": "MDA-MB-134VI treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313070": [{"title": "MDA-MB-134VI treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313071": [{"title": "MDA-MB-134VI treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313072": [{"title": "MDA-MB-134VI treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313073": [{"title": "MDA-MB-134VI treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313074": [{"title": "MDA-MB-134VI treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313075": [{"title": "MDA-MB-134VI untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313076": [{"title": "MDA-MB-134VI untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313077": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313078": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313079": [{"title": "MDA-MB-134VI untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313080": [{"title": "MDA-MB-134VI untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313081": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313082": [{"title": "MDA-MB-134VI treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-134VI_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-134VI;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313083": [{"title": "BT474 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 1"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313084": [{"title": "BT474 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 1"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313085": [{"title": "BT474 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 1"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313086": [{"title": "BT474 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313087": [{"title": "BT474 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313088": [{"title": "BT474 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313089": [{"title": "BT474 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313090": [{"title": "BT474 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313091": [{"title": "BT474 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313092": [{"title": "BT474 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313093": [{"title": "BT474 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313094": [{"title": "BT474 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313095": [{"title": "BT474 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313096": [{"title": "BT474 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313097": [{"title": "BT474 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313098": [{"title": "BT474 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313099": [{"title": "BT474 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313100": [{"title": "BT474 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313101": [{"title": "BT474 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313102": [{"title": "BT474 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313103": [{"title": "BT474 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313104": [{"title": "BT474 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313105": [{"title": "BT474 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313106": [{"title": "BT474 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT474_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313107": [{"title": "BT474 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 5"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313108": [{"title": "BT474 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 5"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313109": [{"title": "BT474 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313110": [{"title": "BT474 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313111": [{"title": "BT474 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 6"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313112": [{"title": "BT474 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474 untreated_day 6"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313113": [{"title": "BT474 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313114": [{"title": "BT474 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT474_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: BT474;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313115": [{"title": "BT-483 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 1"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313116": [{"title": "BT-483 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 1"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313117": [{"title": "BT-483 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 1"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313118": [{"title": "BT-483 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313119": [{"title": "BT-483 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313120": [{"title": "BT-483 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313121": [{"title": "BT-483 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313122": [{"title": "BT-483 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313123": [{"title": "BT-483 treated with 50 ug Siltuximab, day 4_rep4"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313124": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313125": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313126": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313127": [{"title": "BT-483 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313128": [{"title": "BT-483 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313129": [{"title": "BT-483 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313130": [{"title": "BT-483 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313131": [{"title": "BT-483 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313132": [{"title": "BT-483 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313133": [{"title": "BT-483 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313134": [{"title": "BT-483 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313135": [{"title": "BT-483 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313136": [{"title": "BT-483 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313137": [{"title": "BT-483 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313138": [{"title": "BT-483 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313139": [{"title": "BT-483 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 5"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313140": [{"title": "BT-483 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 5"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313141": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313142": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313143": [{"title": "BT-483 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 6"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313144": [{"title": "BT-483 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483 untreated_day 6"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313145": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313146": [{"title": "BT-483 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "BT-483_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: BT-483;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313147": [{"title": "HCC1428 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 1"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313148": [{"title": "HCC1428 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 1"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313149": [{"title": "HCC1428 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 1"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313150": [{"title": "HCC1428 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313151": [{"title": "HCC1428 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313152": [{"title": "HCC1428 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313153": [{"title": "HCC1428 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313154": [{"title": "HCC1428 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313155": [{"title": "HCC1428 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313156": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313157": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313158": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313159": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313160": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313161": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313162": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313163": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313164": [{"title": "HCC1428 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313165": [{"title": "HCC1428 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313166": [{"title": "HCC1428 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313167": [{"title": "HCC1428 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313168": [{"title": "HCC1428 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313169": [{"title": "HCC1428 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313170": [{"title": "HCC1428 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313171": [{"title": "HCC1428 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 5"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313172": [{"title": "HCC1428 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 5"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313173": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313174": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313175": [{"title": "HCC1428 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 6"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313176": [{"title": "HCC1428 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428 untreated_day 6"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313177": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313178": [{"title": "HCC1428 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCC1428_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: HCC1428;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313179": [{"title": "EFM-19 untreated, day 0_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 0"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313180": [{"title": "EFM-19 untreated, day 0_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 0"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313181": [{"title": "EFM-19 untreated, day 0_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 0"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313182": [{"title": "EFM-19 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 1"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313183": [{"title": "EFM-19 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 1"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313184": [{"title": "EFM-19 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 1"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313185": [{"title": "EFM-19 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313186": [{"title": "EFM-19 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313187": [{"title": "EFM-19 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313188": [{"title": "EFM-19 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313189": [{"title": "EFM-19 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313190": [{"title": "EFM-19 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313191": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313192": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313193": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313194": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313195": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313196": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313197": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313198": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313199": [{"title": "EFM-19 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313200": [{"title": "EFM-19 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313201": [{"title": "EFM-19 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313202": [{"title": "EFM-19 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313203": [{"title": "EFM-19 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313204": [{"title": "EFM-19 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313205": [{"title": "EFM-19 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313206": [{"title": "EFM-19 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 5"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313207": [{"title": "EFM-19 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 5"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313208": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313209": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313210": [{"title": "EFM-19 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 6"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313211": [{"title": "EFM-19 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19 untreated_day 6"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313212": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313213": [{"title": "EFM-19 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "EFM-19_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: EFM-19;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313214": [{"title": "MCF-7 untreated, day 0_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 0"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313215": [{"title": "MCF-7 untreated, day 0_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 0"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313216": [{"title": "MCF-7 untreated, day 0_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 0"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313217": [{"title": "MCF-7 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 1"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313218": [{"title": "MCF-7 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 1"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313219": [{"title": "MCF-7 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 1"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313220": [{"title": "MCF-7 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313221": [{"title": "MCF-7 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313222": [{"title": "MCF-7 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313223": [{"title": "MCF-7 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313224": [{"title": "MCF-7 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313225": [{"title": "MCF-7 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313226": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313227": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313228": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313229": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313230": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313231": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313232": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313233": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313234": [{"title": "MCF-7 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313235": [{"title": "MCF-7 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313236": [{"title": "MCF-7 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313237": [{"title": "MCF-7 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313238": [{"title": "MCF-7 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313239": [{"title": "MCF-7 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313240": [{"title": "MCF-7 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313241": [{"title": "MCF-7 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 5"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313242": [{"title": "MCF-7 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 5"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313243": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313244": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313245": [{"title": "MCF-7 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 6"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313246": [{"title": "MCF-7 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 untreated_day 6"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313247": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313248": [{"title": "MCF-7 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MCF-7;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313249": [{"title": "MDA-MB-175-VIIdsRed untreated, day 0_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313250": [{"title": "MDA-MB-175-VIIdsRed untreated, day 0_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313251": [{"title": "MDA-MB-175-VIIdsRed untreated, day 0_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313252": [{"title": "MDA-MB-175-VIIdsRed untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313253": [{"title": "MDA-MB-175-VIIdsRed untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313254": [{"title": "MDA-MB-175-VIIdsRed untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313255": [{"title": "MDA-MB-175-VIIdsRed untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313256": [{"title": "MDA-MB-175-VIIdsRed untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313257": [{"title": "MDA-MB-175-VIIdsRed untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313258": [{"title": "MDA-MB-175-VIIdsRed treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313259": [{"title": "MDA-MB-175-VIIdsRed treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313260": [{"title": "MDA-MB-175-VIIdsRed treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313261": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313262": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313263": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313264": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313265": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313266": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313267": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313268": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313269": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313270": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313271": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313272": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313273": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313274": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313275": [{"title": "MDA-MB-175-VIIdsRed treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313276": [{"title": "MDA-MB-175-VIIdsRed untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313277": [{"title": "MDA-MB-175-VIIdsRed untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313278": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313279": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313280": [{"title": "MDA-MB-175-VIIdsRed untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313281": [{"title": "MDA-MB-175-VIIdsRed untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313282": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313283": [{"title": "MDA-MB-175-VIIdsRed treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-175-VIIdsRed_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-175-VIIdsRed;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313284": [{"title": "MDA-MB-415 untreated, day 0_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313285": [{"title": "MDA-MB-415 untreated, day 0_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313286": [{"title": "MDA-MB-415 untreated, day 0_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 0"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313287": [{"title": "MDA-MB-415 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313288": [{"title": "MDA-MB-415 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313289": [{"title": "MDA-MB-415 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 1"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313290": [{"title": "MDA-MB-415 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313291": [{"title": "MDA-MB-415 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313292": [{"title": "MDA-MB-415 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313293": [{"title": "MDA-MB-415 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313294": [{"title": "MDA-MB-415 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313295": [{"title": "MDA-MB-415 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313296": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313297": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313298": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313299": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313300": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313301": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313302": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313303": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313304": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313305": [{"title": "MDA-MB-415 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313306": [{"title": "MDA-MB-415 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313307": [{"title": "MDA-MB-415 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313308": [{"title": "MDA-MB-415 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313309": [{"title": "MDA-MB-415 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313310": [{"title": "MDA-MB-415 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313311": [{"title": "MDA-MB-415 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313312": [{"title": "MDA-MB-415 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313313": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313314": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313315": [{"title": "MDA-MB-415 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313316": [{"title": "MDA-MB-415 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415 untreated_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313317": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313318": [{"title": "MDA-MB-415 treated with 10 ng/mL IL-6, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-415_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: MDA-MB-415;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313319": [{"title": "ZR-751 untreated, day 0_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 0"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313320": [{"title": "ZR-751 untreated, day 0_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 0"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313321": [{"title": "ZR-751 untreated, day 0_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 0"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 0"}]}, {"GSM1313322": [{"title": "ZR-751 untreated, day 1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 1"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313323": [{"title": "ZR-751 untreated, day 1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 1"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313324": [{"title": "ZR-751 untreated, day 1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 1"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 1"}]}, {"GSM1313325": [{"title": "ZR-751 untreated, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313326": [{"title": "ZR-751 untreated, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313327": [{"title": "ZR-751 untreated, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 4"}]}, {"GSM1313328": [{"title": "ZR-751 treated with 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313329": [{"title": "ZR-751 treated with 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313330": [{"title": "ZR-751 treated with 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313331": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313332": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313333": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 4"}]}, {"GSM1313334": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313335": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313336": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d0 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d0 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D0: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313337": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313338": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313339": [{"title": "ZR-751 treated with 10 ng/mL IL-6 d1 + 50 ug Siltuximab d1, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6 d1 + 50 ug Siltuximab d1_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6 + D1: 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313340": [{"title": "ZR-751 treated with hMSC-CM, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313341": [{"title": "ZR-751 treated with hMSC-CM, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313342": [{"title": "ZR-751 treated with hMSC-CM, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM;\ttime point (day): 4"}]}, {"GSM1313343": [{"title": "ZR-751 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313344": [{"title": "ZR-751 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313345": [{"title": "ZR-751 treated with hMSC-CM + 50 ug Siltuximab, day 4_rep3"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_hMSC-CM + 50 ug Siltuximab_day 4"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: hMSC-CM + 50 ug/mL Siltuximab;\ttime point (day): 4"}]}, {"GSM1313346": [{"title": "ZR-751 untreated, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 5"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313347": [{"title": "ZR-751 untreated, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 5"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 5"}]}, {"GSM1313348": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313349": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 5_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 5"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 5"}]}, {"GSM1313350": [{"title": "ZR-751 untreated, day 6_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 6"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313351": [{"title": "ZR-751 untreated, day 6_rep2"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751 untreated_day 6"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: untreated;\ttime point (day): 6"}]}, {"GSM1313352": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 6_rep1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM1313353": [{"title": "ZR-751 treated with 10 ng/mL IL-6, day 6_rep2_rep1"}, {"type": "RNA"}, {"source_name_ch1": "ZR-751_10 ng/mL IL-6_day 6"}, {"characteristics_ch1": "cell line: ZR-751;\tcell type: ER\u03b1-positive breast cancer cell line;\ttreatment: D1: 10 ng/mL IL-6;\ttime point (day): 6"}]}, {"GSM2281048": [{"title": "35CR_EOS_control_3"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: control, sample: 3"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281049": [{"title": "35CR_EOS_control_4"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: control, sample: 4"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281050": [{"title": "35CR_EOS_control_10"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: control, sample: 10"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281051": [{"title": "35CR_EOS_control_11"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: control, sample: 11"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281052": [{"title": "35CR_EOS_abi_6"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: abi, sample: 6"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281053": [{"title": "35CR_EOS_abi_8"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: abi, sample: 8"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281054": [{"title": "35CR_EOS_abi_14"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: abi, sample: 14"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281055": [{"title": "35CR_EOS_abi_16"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_EOS: abi, sample: 16"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281056": [{"title": "35CR_Day_7_control_1"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: control, sample: 1"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281057": [{"title": "35CR_Day_7_control_2"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: control, sample: 2"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281058": [{"title": "35CR_Day_7_control_7"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: control, sample: 7"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281059": [{"title": "35CR_Day_7_control_9"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: control, sample: 9"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281060": [{"title": "35CR_Day_7_abi_5"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: abi, sample: 5"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281061": [{"title": "35CR_Day_7_abi_12"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: abi, sample: 12"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281062": [{"title": "35CR_Day_7_abi_13"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: abi, sample: 13"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281063": [{"title": "35CR_Day_7_abi_15"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 35CR_Day 7: abi, sample: 15"}, {"characteristics_ch1": "tissue: LuCaP 35CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281064": [{"title": "77_EOS_control_18"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control, sample: 18"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281065": [{"title": "77_EOS_control_19"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control, sample: 19"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281066": [{"title": "77_EOS_control_20"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control, sample: 20"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281067": [{"title": "77_EOS_control_21"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control, sample: 21"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281068": [{"title": "77_EOS_control_29"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control, sample: 29"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281069": [{"title": "77_EOS_control_CX_17"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control CX, sample: 17"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281070": [{"title": "77_EOS_control_CX_24"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control CX, sample: 24"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281071": [{"title": "77_EOS_control_CX_25"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control CX, sample: 25"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281072": [{"title": "77_EOS_control_CX_27"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control CX, sample: 27"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281073": [{"title": "77_EOS_control_CX_28"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: control CX, sample: 28"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281074": [{"title": "77_EOS_abi_22"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: abi, sample: 22"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281075": [{"title": "77_EOS_abi_23"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: abi, sample: 23"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281076": [{"title": "77_EOS_abi_26"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: abi, sample: 26"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281077": [{"title": "77_EOS_abi_30"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: abi, sample: 30"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281078": [{"title": "77_EOS_abi_31"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 77_EOS: abi, sample: 31"}, {"characteristics_ch1": "tissue: LuCaP 77 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281079": [{"title": "96CR_EOS_control_33"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: control, sample: 33"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281080": [{"title": "96CR_EOS_control_40"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: control, sample: 40"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281081": [{"title": "96CR_EOS_control_44"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: control, sample: 44"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281082": [{"title": "96CR_EOS_control_45"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: control, sample: 45"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281083": [{"title": "96CR_EOS_abi_32"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: abi, sample: 32"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281084": [{"title": "96CR_EOS_abi_36"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: abi, sample: 36"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281085": [{"title": "96CR_EOS_abi_39"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: abi, sample: 39"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281086": [{"title": "96CR_EOS_abi_41"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: abi, sample: 41"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281087": [{"title": "96CR_EOS_abi_46"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_EOS: abi, sample: 46"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281088": [{"title": "96CR_Day_7_control_34"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: control, sample: 34"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281089": [{"title": "96CR_Day_7_control_37"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: control, sample: 37"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281090": [{"title": "96CR_Day_7_control_42"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: control, sample: 42"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281091": [{"title": "96CR_Day_7_control_48"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: control, sample: 48"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281092": [{"title": "96CR_Day_7_abi_35"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: abi, sample: 35"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281093": [{"title": "96CR_Day_7_abi_38"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: abi, sample: 38"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281094": [{"title": "96CR_Day_7_abi_43"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: abi, sample: 43"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281095": [{"title": "96CR_Day_7_abi_47"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 96CR_Day 7: abi, sample: 47"}, {"characteristics_ch1": "tissue: LuCaP 96CR PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281096": [{"title": "136_EOS_control_51"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control, sample: 51"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281097": [{"title": "136_EOS_control_57"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control, sample: 57"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281098": [{"title": "136_EOS_control_60"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control, sample: 60"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281099": [{"title": "136_EOS_control_68"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control, sample: 68"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control"}]}, {"GSM2281100": [{"title": "136_EOS_control_CX_50"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 50"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281101": [{"title": "136_EOS_control_CX_52"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 52"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281102": [{"title": "136_EOS_control_CX_58"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 58"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281103": [{"title": "136_EOS_control_CX_59"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 59"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281104": [{"title": "136_EOS_control_CX_63"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 63"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281105": [{"title": "136_EOS_control_CX_66"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: control CX, sample: 66"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: control CX"}]}, {"GSM2281106": [{"title": "136_EOS_abi_55"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: abi, sample: 55"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281107": [{"title": "136_EOS_abi_65"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: abi, sample: 65"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281108": [{"title": "136_EOS_abi_67"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: abi, sample: 67"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281109": [{"title": "136_EOS_abi_70"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_EOS: abi, sample: 70"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: EOS;\ttreatment group: abi"}]}, {"GSM2281110": [{"title": "136_Day_7_control_54"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: control, sample: 54"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281111": [{"title": "136_Day_7_control_56"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: control, sample: 56"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281112": [{"title": "136_Day_7_control_61"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: control, sample: 61"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281113": [{"title": "136_Day_7_control_62"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: control, sample: 62"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: control"}]}, {"GSM2281114": [{"title": "136_Day_7_abi_49"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: abi, sample: 49"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281115": [{"title": "136_Day_7_abi_53"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: abi, sample: 53"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281116": [{"title": "136_Day_7_abi_64"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: abi, sample: 64"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}, {"GSM2281117": [{"title": "136_Day_7_abi_69"}, {"type": "RNA"}, {"source_name_ch1": "LuCaP 136_Day 7: abi, sample: 69"}, {"characteristics_ch1": "tissue: LuCaP 136 PDX tumor;\ttimepoint group: Day 7;\ttreatment group: abi"}]}]}